drugset / Trial / NCT03071172
Clinical Study of Recombinant Human Follitropin for Injection Assisted in COH Assisted IVF-ET
Phase 3
Unknown
252 enrolled
Changchun GeneScience Pharmaceutical Co., Ltd.
Peking University Third Hospital · collabSixth Affiliated Hospital, Sun Yat-sen University · collabSun Yat-Sen Memorial Hospital of Sun Yat-Sen University · collabThe First Affiliated Hospital of Anhui Medical University · collabThe First Affiliated Hospital with Nanjing Medical University · collabWomen's Hospital School Of Medicine Zhejiang University · collabXiangya Hospital of Central South University · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The aim of this study was to evaluate the efficacy and safety of domestic recombinant human follicle stimulating hormone (rhFSH) stimulating ovarian to promote follicular development before assisted reproductive technology, which was non-inferiority than that of the imported rhFSH.
Timeline
- Start
- 2017-03
- Primary completion
- 2017-12
- Completion
- 2018-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Progesterone Soft Capsules | Unknown | — | — |
| Background | Recombinant Human Choriogonadotropin alfa Solution for Injection | Unknown | — | — |
| Background | Triptorelin for Injection | Unknown | — | — |